Category: Ibogaine
-
Lophos Pharmaceuticals (MESC.C) expands licensing to include just about all the drugs
There’s no better due diligence in the psychoactive drug space than Health Canada. Loads of pharma companies have investor decks that promise they’ll one day be in the psychedelics business, the MDMA business, even mescaline, but getting licensed to be involved in those spaces is not an easy thing. Lophos Pharmaceuticals Corp (MESC.C) recently received…
-
If I had a billion dollars: psychedelics sector edition
The Bare Naked Ladies made “if I had a million dollars,” famous, as they tunefully explained what they would do with their riches. However, in the post-crisis everything bubble, that speculative fantasy no longer bears the same relevance and needs to be ramped up insanely to have any impact. As a thought experiment, let’s pretend…
-
Small cap psychedelics stocks – Today’s Idea
The psychedelics space is loaded with over-valued unicorns and also-rans, making it difficult for investors to find real growth opportunities. Here are some companies in the sector that have differentiated themselves, let’s examine them and their potential value: Mind Cure Health (MCUR.C) is based in Vancouver, Canada and according to its website is a company…
-
Mind Cure Health (MCUR.C): a hidden psychedelics gem – Today’s Idea
The World Health Organization (WHO) has listed depression as a leading cause of disability worldwide and a major contributor to the overall global burden of disease. Unfortunately, traditional treatments aren’t providing the sustainable answers we need, so companies like Mind Cure Health (MCUR.C) have integrated ancient therapeutics with modern modalities and technologies to effectively heal…